GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 89 filers reported holding GW PHARMACEUTICALS PLC in Q4 2014. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $225,000 | -32.4% | 2,311 | -21.7% | 0.01% | -7.7% |
| Q1 2018 | $333,000 | -12.6% | 2,953 | -6.2% | 0.01% | -7.1% |
| Q1 2017 | $381,000 | +37.5% | 3,148 | +4.1% | 0.01% | +27.3% |
| Q2 2016 | $277,000 | -13.7% | 3,025 | -14.1% | 0.01% | 0.0% |
| Q1 2015 | $321,000 | +9.2% | 3,521 | -18.8% | 0.01% | +10.0% |
| Q4 2014 | $294,000 | – | 4,338 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |